Shares of Thermo Fisher Scientific Inc. TMO slid 1.48% to $597.75 Friday, on what proved to be an all-around dismal trading ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $665.00.

Citi analyst Patrick B Donnelly maintained a Hold rating on Thermo Fisher (TMO – Research Report) yesterday and set a price target of ...

Shares of Thermo Fisher Scientific surged Thursday after the life sciences titan beat Wall Street's fourth-quarter expectations.

Thermo Fisher Scientific on Thursday forecast annual profit above Wall Street estimates, banking on improved demand for its products and services used in developing therapies, sending its shares up 6.

Ataccama is a data quality company that helps organisations organise, understand and improve their data. The company recently ...

Azenta, Inc. shares have surged over 30% since Nov 2024 due to S&P 600 inclusion and an analyst upgrade, despite somewhat ...

Four of our panelists discuss their favorite investments in the final installment of our 2025 stock-picking confab.

Put simply, without adequate cash flow, it becomes difficult for any company to sustain its operations, let alone continue to ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Szyman led Edwards Lifesciences’ critical care unit for more than a decade before BD acquired the group last year. Her ...